Nov 1, 2023

Combining cell types may lead to improved cardiac cell therapy following heart attack

Posted by in categories: biotech/medical, futurism

Researchers at the University of Wisconsin–Madison and Academia Sinica of Taiwan have harnessed a combination of lab-grown cells to regenerate damaged heart muscle.

The study is published in Circulation. It addresses major challenges of using cells, called cardiomyocytes, grown from , and takes a crucial step toward future clinical applications.

Previous research has shown that transplanting cardiomyocytes made from induced (iPSC) can replace muscle in the hearts of mammals. Researchers have struggled to bring the treatment to the clinic, in part because the implanted cells haven’t developed enough life-sustaining blood vessels to survive very long.

Leave a reply